Multiple myeloma trials in China

203 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Early phase 1Not yet taking people in China
  A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy

  Where

  Hangzhou

  Age

  30 years to 75 years

  People

  50

  Run by

  Zhejiang University

  See details and how to joinNCT04541368
• Phase 1/2Taking people
  Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients

  Where

  Suzhou

  Age

  18 years to 80 years

  People

  50

  Run by

  The First Affiliated Hospital of Soochow University

  See details and how to joinNCT04025450
• Phase 1/2Taking people
  Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma

  Where

  Suzhou

  Age

  18 years to 75 years

  People

  10

  Run by

  The First Affiliated Hospital of Soochow University

  See details and how to joinNCT03196414